首页> 外文期刊>International archives of allergy and immunology >Parasite Infections, Allergy and Asthma: A Role for Tropomyosin in Promoting Type 2 Immune Responses
【24h】

Parasite Infections, Allergy and Asthma: A Role for Tropomyosin in Promoting Type 2 Immune Responses

机译:寄生虫感染,过敏和哮喘:对促进2型免疫应答的对卓越素的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: The relationship of parasite infections and promotion or protection from allergy and asthma is controversial. Currently, over 1.5 billion people are infected with parasites worldwide, and Ascaris lumbricoides is the most frequent soil-transmitted helminth. Objectives: To evaluate the biological activity of recombinant A. lumbricoides tropomyosin and investigate IgE cross-reactive responses to tropomyosins by means of microarray methodology for the detection of sensitization to allergen components. Methods: Forty patients 12-75 years of age (25 males) with asthma and/or rhinitis and 10 nonallergic control subjects participated in this study. All patients presented positive skin tests to cockroach extracts and underwent skin prick testing (SPT) with recombinant (r) tropomyosins rPer a 7 from Periplaneta americana and rAsc l 3 from A. lumbricoides, at 10 mu g/mL. IgE to cockroach and parasite tropomyosins were measured by chimeric ELISA and ImmunoCAP-ISAC, and total IgE was quantitated by ImmunoCAP. Agreement of results was assessed by kappa statistics. Results: Recombinant A. lumbricoides showed biological activity, inducing positive skin tests in 50% patients with asthma and/or rhinitis. IgE to cockroach and parasite tropomyosins were detected in 55-62% of patients. There was good-to-excellent agreement of results of SPT and IgE measurements by ELISA and ImmunoCAP-ISAC, with kappa indices of 0.66-0.95. No skin test reactivity or IgE antibodies to tropomyosins were found in nonallergic individuals. Conclusions: Our results suggest that IgE responses to tropomyosin from A. lumbricoides may enhance reactivity to homologous allergens upon exposure by inhalation or ingestion, promoting allergic reactions and asthma, or increasing the severity of these clinical conditions.
机译:介绍:寄生虫感染和促进或免受过敏和哮喘的关系是有争议的。目前,在全球寄生虫中有超过15亿人感染,蛔虫株是最常见的土壤传播的蠕虫。目的:评价重组A.植物植物的生物活性,通过微阵列方法研究对对抗性的对抗对抗素的IgE交叉反应反应进行检测到过敏原组分的敏化。方法:本研究参加了哮喘和/或鼻炎12-75岁(25名男性)的四十名患者,参加了10例哮喘和鼻炎。所有患者向蟑螂提取物呈现阳性皮肤测试,并从A.植物中的Periplaneta Americana和Rasc13的Refombinant(R)Trophomyosins rper a 7,从A.劳累曲线曲线,10μg/ ml,患有重组(R)Trophomyosins RPER A 7。通过嵌合ELISA和Immuncocap-Isac测量IgE对蟑螂和寄生虫对抗植物,通过免疫焦点定量总IgE。 Kappa统计评估结果的协议。结果:重组A.植物显示生物活性,诱导50%哮喘和/或鼻炎患者的阳性皮肤试验。在55-62%的患者中检测到蟑螂和寄生虫对寄生虫。 ELISA和Immunocap-Isac的SPT和IgE测量结果有良好的良好协议,其中kappa指数为0.66-0.95。在非高效个体中没有发现皮肤测试反应性或对原猪的IgE抗体。结论:我们的研究结果表明,IgE对来自A.肉瘤的对抗植物的反应可以通过吸入或摄取,促进过敏反应和哮喘,或增加这些临床病症的严重程度,增强对同源过敏原的反应性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号